前言目的:探讨血清可溶性细胞间粘附分子1(sICAM-1)在
新生儿败血症早期诊断中的价值。方法:采用双抗体夹心酶联免疫吸附试验,观察3组新生儿血清sICAM-1水平。
脐血组:34例正常新生儿脐血。对照组:25例非感染性疾病新生儿。败血症组:33例治疗前(入院第1d)及有效治疗后7~18d(出院当天)的败血症新生儿。结果:血清sICAM-1水平3组间有显著差异(P<0。01)。败血症组治疗前明显增高,治疗后略有下降,但治疗前后比较差异无意义(P>0。05);血培养阳性与阴性之间比较,不同程度败血症治疗前与治疗后比较,差异均无意义(P均>0。05)。结论:血清sICAM-1测定可作为新生儿败血症早期诊断指标,但不能评判疗效
Objective:Toinvestigatetheclinicalsignificanceofserumsolubleintercellularadhesionmoleculel(sICAM1)forearlydiagnosisofneonatalsepsis.Methods:ThesandwichenzymelinkedimmunosorbentassaywasusedtomeasuresICAM1in34samplesofnormalneonatalcordblood(GroupⅠ),25normalnewborns(GroupⅡ),33casesofneonatalsepsis(8withpositivebloodcultureand25negative)beforetreatmentandafterrecovery(GroupⅢ).Results:ThereweresignificantdifferenceinsICAM1levelsamongⅠ,...